Open-Angle Glaucoma

Uses

How it works

Dosage & preparation

Background

Evidence quality

Highlighted claims

• The study eye must demonstrate perimetric progression of at least 1.5 dB per year to qualify. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• The TES-GPS study enrolls patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, pigment dispersion glaucoma, or normal-tension glaucoma. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• Open-angle glaucoma is a leading cause of irreversible blindness worldwide. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• Increased intraocular pressure is the main modifiable risk factor for open-angle glaucoma. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
• Standard pressure-lowering treatment does not prevent visual field loss in all patients. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol